Capsule
NEFECON MODIFIED-RELEASE CAPSULES 4MG
Summary
NEFECON MODIFIED-RELEASE CAPSULES 4MG — Capsule containing budesonide. Hong Kong Registration No. HK-68212. Certificate Holder: EVEREST MEDICINES II (HK) LIMITED. Date of Registration: 29 Apr, 2024.
Product NameNEFECON MODIFIED-RELEASE CAPSULES 4MG
Registration No.HK-68212
Certificate HolderEVEREST MEDICINES II (HK) LIMITED
Holder AddressUNIT 417, 4/F, LIPPO CENTRE TOWER TWO, NO. 89 QUEENSWAY, ADMIRALTY, HONG KONG
Ingredientsbudesonide
Dosage FormCapsule
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration29 Apr, 2024
ATC codesA07EA06, D07AC09, R01AD05, R03BA02
ATC Classification
ATC level 1
A Alimentary Tract and Metabolism / D Dermatologicals / R Respiratory System
All ATC groupsA07, D07, R01, R03
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。